Comparison of Two Real-Time Quantitative Assays for Detection of Severe Acute Respiratory Syndrome Coronavirus

Journal of Clinical Microbiology

Volumn 42, Issue 5, 2004, Pages 2094-2100

  Hourfar, Michael K ^a   Roth, W Kurt ^a   Seifried, Erhard ^a   Schmidt, Michael ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ANIMAL CELL; ARTICLE; BLOOD TRANSFUSION; CAUSE OF DEATH; CELL CULTURE; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; GAMMA IRRADIATION; GENE AMPLIFICATION; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY FAILURE; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; SPUTUM ANALYSIS; STANDARD; VERO CELL; VIRUS DETECTION; VIRUS TRANSMISSION;

HUMANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SARS VIRUS; SENSITIVITY AND SPECIFICITY; SEVERE ACUTE RESPIRATORY SYNDROME; VIROLOGY;

ANIMALIA; CORONAVIRUS; RNA VIRUSES; SARS CORONAVIRUS;

EID: 2442462302     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.42.5.2094-2100.2004     Document Type: Article

References (20)

1. Abbott, A. 2003. Pet theory comes to the fore in fight against SARS. Nature 423:576
2. Al-Soud, W. A., L. J. Jonsson, and P. Radstrom. 2000. Identification and characterization of immunoglobulin G in blood as a major inhibitor of diagnostic PCR. J. Clin. Microbiol. 38:345-350.
3. Anonymous. 2003. FactSheet: severe acute respiratory syndrome (SARS). N. S. W. Public Health Bull. 14:62.
4. Bland, J. M., and D. G. Altman. 1986. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1:307-310.
5. Bustin, S. A. 2000. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J. Mol. Endocrinol. 25:169-193.
6. Centers for Disease Control and Prevention. 2003. Outbreak of severe acute respiratory syndrome-worldwide, 2003. Morb. Mortal. Wkly. Rep. 52:226-228.
7. Cusi, M. G., M. Valassina, and P. E. Valensin. 1994. Comparison of M-MLV reverse transcriptase and Tth polymerase activity in RT-PCR of samples with low virus burden. BioTechniques 17:1034-1036.
8. Das, M., I. Harvey, L. L. Chu, M. Sinha, and J. Pelletier. 2001. Full-length cDNAs: more than just reaching the ends. Physiol. Genomics 6:57-80.
9. Drosten, C., S. Gunther, W. Preiser, S. van der Werf, H. R. Brodt, S. Becker, H. Rabenau, M. Panning, L. Kolesnikova, R. A. Fouchier, A. Berger, A. M. Burguiere, J. Cinatl, M. Eickmann, N. Escriou, K. Grywna, S. Kramme, J. C. Manuguerra, S. Muller, V. Rickerts, M. Sturmer, S. Vieth, H. D. Klenk, A. D. Osterhaus, H. Schmitz, and H. W. Doerr. 2003. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N. Engl. J. Med. 348:1967-1976.
10. Grabko, V. I., L. G. Chistyakova, V. N. Lyapustin, V. G. Korobko, and A. I. Miroshnikov. 1996. Reverse transcription, amplification and sequencing of poliovirus RNA by Taq DNA polymerase. FEBS Lett. 387:189-192.
11. Hamaguchi, Y., Y. Aso, H. Shimada, and M. Mitsuhashi. 1998. Direct reverse transcription-PCR on oligo(dT)-immobilized polypropylene microplates after capturing total mRNA from crude cell lysates. Clin. Chem. 44:2256-2263.
12. Herrmann, B., C. Larsson, and B. W. Zweygberg. 2001. Simultaneous detection and typing of influenza viruses A and B by a nested reverse transcription-PCR: comparison to virus isolation and antigen detection by immunofluorescence and optical immunoassay (FLU OIA). J. Clin. Microbiol. 39:134-138.
13. Lai, K. K., L. Cook, S. Wendt, L. Corey, and K. R. Jerome. 2003. Evaluation of real-time PCR versus PCR with liquid-phase hybridization for detection of enterovirus RNA in cerebrospinal fluid. J. Clin. Microbiol. 41:3133-3141.
14. Myers, T. W., and D. H. Gelfand. 1991. Reverse transcription and DNA amplification by a Thermus thermophilus DNA polymerase. Biochemistry 30:7661-7666.
15. Peiris, J. S., C. M. Chu, V. C. Cheng, K. S. Chan, I. F. Hung, L. L. Poon, K. I. Law, B. S. Tang, T. Y. Hon, C. S. Chan, K. H. Chan, J. S. Ng, B. J. Zheng, W. L. Ng, R. W. Lai, Y. Guan, and K. Y. Yuen. 2003. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 361:1767-1772.
16. Poddar, S. K., M. H. Sawyer, and J. D. Connor. 1998. Effect of inhibitors in clinical specimens on Taq and Tth DNA polymerase-based PCR amplification of influenza A virus. J. Med. Microbiol. 47:1131-1135.
17. Schmidt, M., V. Brixner, B. Ruster, M. K. Hourfar, C. Drosten, W. Preiser, E. Seifried and W. K. Roth. 2004. NAT screening of blood donors for SARS corona virus can potentially prevent transfusion associated transmissions. Transfusion 44:470-475.
18. Spurgeon, D. 2003. Toronto succumbs to SARS a second time. BMJ 326:1162.
19. World Health Organization. 2003. Update 71. Status of diagnostic tests, training course in China. World Health Organization, Geneva, Switzerland.
20. Zhang, J., B. Meng, D. Liao, L. Zhou, X. Zhang, L. Chen, Z. Guo, C. Peng, B. Zhu, K. L., P. P. Lee, X. Xu, T. Zhou, Z. Deng, and Y. Hu. 2003. De novo synthesis of PCR templates for the development of SARS diagnostic assay. Mol. Biotechnol. 25:107-112.